WEST LAFAYETTE, IN--(Marketwire - October 14, 2009) - Bioanalytical Systems, Inc. (NASDAQ: BASI) announced today that David L. Omachinski has been elected to the
Board of Directors of the company.
Mr. Omachinski, 57, is currently an executive management consultant. From
1993 to 2005, he served in various executive management positions with
Oshkosh B'Gosh, Inc., including President, Chief Operating Officer, Chief
Financial Officer, Vice President of Finance and Treasurer. Mr. Omachinski
also previously held various executive roles with Schumaker, Romenesko &
Associates, S.C., a Wisconsin-based, full service, regional accounting
"We are very pleased David will be joining the Board. He has broad
financial experience and his knowledge and insights will provide a valuable
perspective to our Board," said BASi Board Chairman William E. Baitinger.
Mr. Omachinski also serves on the board of Anchor BanCorp Wisconsin, Inc.
since 1999, the University of Wisconsin-Oshkosh Foundation since 2003, and
Chamco, Inc. since 2002. Mr. Omachinski received his Bachelor of Business
Administration from the University of Wisconsin-Oshkosh and is a certified
BASi is a pharmaceutical development company providing contract research
services and monitoring instruments to the world's leading drug development
companies and medical research organizations. The company focuses on
developing innovative services and products that increase efficiency and
reduce the cost of taking a new drug to market. Visit www.BASInc.com for
This release contains forward-looking statements that are subject to risks
and uncertainties including, but not limited to, those market and operating
risks detailed in the company's filings with the Securities and Exchange